{
    "ticker": "GENE",
    "name": "Genetic Technologies Limited",
    "description": "Genetic Technologies Limited is a biotechnology company focused on advancing healthcare and improving patient outcomes through the development of innovative genetic testing solutions. Founded in 1989 and headquartered in Melbourne, Australia, GENE specializes in the field of predictive genetics and personalized medicine. The company's flagship product, GeneType\u2122, is a risk assessment tool that evaluates an individual's genetic predisposition to various health conditions, including certain cancers and chronic diseases. By leveraging advanced genomic technologies, Genetic Technologies aims to empower healthcare providers and patients with actionable insights that facilitate early detection and preventive care. The company's commitment to research and development is underscored by its collaborations with leading academic institutions and research organizations. As the field of genetics continues to evolve, GENE is at the forefront, advocating for the integration of genetic testing into routine healthcare practices to enhance disease prevention and management. Genetic Technologies is dedicated to providing reliable, accurate, and clinically relevant genetic information, aiming to transform the way healthcare is delivered and improve overall public health.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Melbourne, Victoria, Australia",
    "founded": "1989",
    "website": "https://www.genetictechnologies.com",
    "ceo": "John McKinley",
    "social_media": {
        "twitter": "https://twitter.com/GeneticTech",
        "linkedin": "https://www.linkedin.com/company/genetic-technologies-limited/"
    },
    "investor_relations": "https://www.genetictechnologies.com/investor-relations",
    "key_executives": [
        {
            "name": "John McKinley",
            "position": "CEO"
        },
        {
            "name": "Rachael Dunlop",
            "position": "Chief Scientific Officer"
        }
    ],
    "product_categories": [
        {
            "category": "Genetic Testing",
            "products": [
                "GeneType\u2122"
            ]
        }
    ],
    "seo": {
        "meta_title": "Genetic Technologies Limited | Innovating Genetic Testing Solutions",
        "meta_description": "Explore Genetic Technologies Limited, a leader in biotechnology focused on predictive genetic testing and personalized medicine. Discover how GENE is transforming healthcare.",
        "keywords": [
            "Genetic Technologies",
            "Genetic Testing",
            "Predictive Genetics",
            "Personalized Medicine",
            "GeneType"
        ]
    },
    "faq": [
        {
            "question": "What does Genetic Technologies specialize in?",
            "answer": "Genetic Technologies specializes in predictive genetics and personalized medicine through innovative genetic testing solutions."
        },
        {
            "question": "What is GeneType\u2122?",
            "answer": "GeneType\u2122 is a risk assessment tool that evaluates an individual's genetic predisposition to various health conditions."
        },
        {
            "question": "Where is Genetic Technologies headquartered?",
            "answer": "Genetic Technologies is headquartered in Melbourne, Victoria, Australia."
        },
        {
            "question": "When was Genetic Technologies founded?",
            "answer": "Genetic Technologies was founded in 1989."
        }
    ],
    "competitors": [
        "ILMN",
        "NVTA",
        "EXAS"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "REGN",
        "BMY"
    ]
}